RXRX
Price
$3.30
Change
-$0.26 (-7.30%)
Updated
Jul 13 closing price
Capitalization
1.89B
29 days until earnings call
Intraday BUY SELL Signals
SNTI
Price
$0.97
Change
-$0.06 (-5.83%)
Updated
Jul 13, 04:59 PM (EDT)
Capitalization
32.08M
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RXRX vs SNTI

RXRX vs SNTI Comparison Chart in %
View a ticker or compare two or three
VS
RXRX vs. SNTI commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Buy and SNTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (RXRX: $3.56 vs. SNTI: $1.03)
Brand notoriety: RXRX and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 77% vs. SNTI: 55%
Market capitalization -- RXRX: $1.75B vs. SNTI: $30.05M
RXRX [@Biotechnology] is valued at $1.75B. SNTI’s [@Biotechnology] market capitalization is $30.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 1 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 1 green, 4 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, both RXRX and SNTI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 5 TA indicator(s) are bullish while SNTI’s TA Score has 4 bullish TA indicator(s).

  • RXRX’s TA Score: 5 bullish, 4 bearish.
  • SNTI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both RXRX and SNTI are a good buy in the short-term.

Price Growth

RXRX (@Biotechnology) experienced а -6.32% price change this week, while SNTI (@Biotechnology) price change was -3.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.13%. For the same industry, the average monthly price growth was +7.30%, and the average quarterly price growth was +1806.57%.

Reported Earning Dates

RXRX is expected to report earnings on Aug 11, 2026.

SNTI is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-3.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.89B) has a higher market cap than SNTI($32.1M). SNTI YTD gains are higher at: -0.962 vs. RXRX (-12.958). SNTI has higher annual earnings (EBITDA): -55.43M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. SNTI (8.94M). SNTI has less debt than RXRX: SNTI (19.1M) vs RXRX (72.4M). RXRX has higher revenues than SNTI: RXRX (65.7M) vs SNTI (38K).
RXRXSNTIRXRX / SNTI
Capitalization1.89B32.1M5,888%
EBITDA-478.66M-55.43M864%
Gain YTD-12.958-0.9621,348%
P/E RatioN/A4.27-
Revenue65.7M38K172,895%
Total Cash654M8.94M7,320%
Total Debt72.4M19.1M379%
TECHNICAL ANALYSIS
Technical Analysis
RXRXSNTI
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
65%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
59%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
66%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
RXRX
Daily Signal:
Gain/Loss:
SNTI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CROX132.785.65
+4.44%
Crocs
STX910.3420.25
+2.28%
Seagate Technology Holdings PLC
ARDT10.08-0.01
-0.10%
Ardent Health Inc
FDBC50.45-0.40
-0.79%
Fidelity D & D Bancorp
BRFH1.95-0.04
-2.01%
Barfresh Food Group

SNTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+3.00%
PPBT - SNTI
58%
Loosely correlated
-5.18%
DYN - SNTI
43%
Loosely correlated
-3.50%
INBX - SNTI
41%
Loosely correlated
-10.44%
BDRX - SNTI
40%
Loosely correlated
-3.86%
RXRX - SNTI
39%
Loosely correlated
-5.32%
More